ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia

Stephen G. Landt(Stanford University), Georgi K. Marinov(California Institute of Technology), Anshul Kundaje(Stanford University), Pouya Kheradpour(Massachusetts Institute of Technology), Florencia Pauli(HudsonAlpha Institute for Biotechnology), Serafim Batzoglou(Stanford University), B Bernstein(Broad Institute), Peter J. Bickel(University of California, Berkeley), James B. Brown(University of California, Berkeley), Philip Cayting(Stanford University), Yiwen Chen(Dana-Farber Cancer Institute), Gilberto DeSalvo(California Institute of Technology), Charles B. Epstein(Broad Institute), Katherine Fisher-Aylor(California Institute of Technology), Ghia Euskirchen(Stanford University), Mark Gerstein(Yale University), Jason Gertz(HudsonAlpha Institute for Biotechnology), Alexander J. Hartemink(Duke University), Michael M. Hoffman(University of Washington), Vishwanath R. Iyer(The University of Texas at Austin), Youngsook L. Jung(Brigham and Women's Hospital), Subhradip Karmakar(University of Chicago), Manolis Kellis(Massachusetts Institute of Technology), Peter V. Kharchenko(The University of Texas at Austin), Qunhua Li(Pennsylvania State University), Tao Liu(Dana-Farber Cancer Institute), X. Shirley Liu(Dana-Farber Cancer Institute), Lijia Ma(University of Chicago), Aleksandar Milosavljevic(Baylor College of Medicine), R Myers(HudsonAlpha Institute for Biotechnology), Peter J. Park(Brigham and Women's Hospital), Michael J. Pazin(National Institutes of Health), Marc D. Perry(Ontario Institute for Cancer Research), Debasish Raha(Yale University), Timothy E. Reddy(HudsonAlpha Institute for Biotechnology), Joel Rozowsky(Yale University), Noam Shoresh(Broad Institute), Arend Sidow(Stanford University), Matthew Slattery(University of Chicago), J Stamatoyannopoulos(University of Washington), Michael Tolstorukov(Brigham and Women's Hospital), Kevin P. White(University of Chicago), Simon Xi(University of Massachusetts Chan Medical School), Peggy Farnham(University of Southern California), Jason D. Lieb(University of North Carolina at Chapel Hill), B Wold(California Institute of Technology), M Snyder(Stanford University)
Genome Research
September 1, 2012
Cited by 2,216Open Access
Full Text

Abstract

Chromatin immunoprecipitation (ChIP) followed by high-throughput DNA sequencing (ChIP-seq) has become a valuable and widely used approach for mapping the genomic location of transcription-factor binding and histone modifications in living cells. Despite its widespread use, there are considerable differences in how these experiments are conducted, how the results are scored and evaluated for quality, and how the data and metadata are archived for public use. These practices affect the quality and utility of any global ChIP experiment. Through our experience in performing ChIP-seq experiments, the ENCODE and modENCODE consortia have developed a set of working standards and guidelines for ChIP experiments that are updated routinely. The current guidelines address antibody validation, experimental replication, sequencing depth, data and metadata reporting, and data quality assessment. We discuss how ChIP quality, assessed in these ways, affects different uses of ChIP-seq data. All data sets used in the analysis have been deposited for public viewing and downloading at the ENCODE (http://encodeproject.org/ENCODE/) and modENCODE (http://www.modencode.org/) portals.


Related Papers